In line with our in vitro studies, Spns2 mRNA was found to be down-regulated in advanced stage LC patient samples (Fig. 7) when compared to normal adjacent controls from the same patients. The gene discussed is SPNS2; the disease is laryngotracheoesophageal cleft.